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In  the  mouse,  a  number of serological markers  are  reported to be expressed on 
natural killer (NK) x cells, including NKI (1, 2), Ly-5 (3), Qa-2, Qa-4, and Qa-5 (4, 5), 
asialo GM1 (6), Thy- 1 (7), and Mph- 1 (8). The conflicting evidence on the phenotypes 
and characteristics of NK cells in various systems can best be reconciled if NK cells 
are not a  single cell type derived from a common lineage, but represent a  heteroge- 
neous population of  cells sharing the capability of selective cytotoxicity. The possibility 
that NK cells were heterogeneous was initially suggested by the important experiments 
of Stutman et al.  (9,  10) and Burton (2), which indicated that spontaneous cytotoxic 
effector cells active on solid tumor cells have characteristics different from the NK 
cells that  kill  lymphoma cell targets,  e.g., cell surface markers,  organ  distribution, 
strain distribution, and radiation sensitivity. Kumar et al.  (I 1) observed that mouse 
NK activity on EL4 target cells had different sensitivity to bone marrow irradiation 
by 89Sr from  that  on  YAC  tumor  cells.  Lohman-Matthes  et  al.  (8)  reported that 
cultured bone marrow cells could exert NK-like activity, and that such cells shared 
common surface antigenic determinants with mononuclear phagocytes. 
In  previous  work  (12),  we  have  attempted  to  define  some  of the  genetically 
determined serological markers on mouse NK cells effective against virus persistently 
infected xenogeneic tumor  cells  and,  using such  markers,  were  able  to show  that 
interferon  acts  on  a  precursor  cell  stimulating  its  differentiation  into  a  cytolytic 
effector NK cell. In the present report we have analyzed the heterogeneity of NK cells 
in mice and identified at least four phenotypieally distinct cytotoxic effector cells that 
differ  not  only  in  their  surface  markers,  but  also  in  their  responsiveness  to  the 
regulatory influences of interferon (IFN) and interleukin 2 (IL-2). 
Materials and Methods 
Mice.  C57BL/6 mice  (B/6)  were purchased from The Jackson Laboratory (Bar Harbor, 
Maine). C57BL/6 be~be and nu/nu, and CBA/N nu/nu mice were originally supplied by Dr. K. 
Hansen  (National  Institutes  of Health),  and  bred  in  our  own  colonies.  Throughout  the 
experiments, 6-8-wk-old  mice were used. 
Tumor Cells.  HeLa ceils persistently  infected with measles virus (HeLa-Ms), the character- 
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isties of which have been described elsewhere (13), were grown in Dulbecco's modified minimal 
essential medium supplemented with 8% calf serum. P815 cells were grown in RPMI 1640 with 
10% fetal calf serum. 
Cell Cultures.  Single cell suspensions of various mouse lymphoid organs including thymus, 
spleen, and bone marrow were cultured in RPMI  1640 medium supplemented with strepto- 
mycin, penicillin, 2 mM L-glutamine, 5 ×  10  -5 M  2-mercaptoethanol, and 10% fetal calf serum 
(FCS) in 7% CO2 in air. The cell concentration was  1 ×  107 cells/ml for thymus and spleen 
cells, and 5 ×  l0  s cell/ml for bone marrow cells. 
Antiserum Treatment.  Monoclonal anti-Thy-1.2 ascites (New England Nuclear, Boston, Mass.) 
was used at a final dilution of 5 ×  10  -3, and monoclonal anti-Qa-5 ascites (a generous gift from 
Dr.  U.  Hammerling, Sloan-Kettering Institute, New  York)  were used at a  final dilution of 
1:10-2;  anti-Lyt-l.2 serum, anti-Lyt-2.2 monoclonal antibody, and anti-Ly-5.1 serum (kindly 
supplied by Dr.  H. Cantor, Sidney Farber Cancer Center, Boston, Mass.) were used at  1:20, 
1:60, and 1:40 final dilutions, respectively. The cells at densities of 5 ×  10  s- 1 ×  107/0.5 ml were 
treated  either in  single step  with  anti-Thy-l.2 or anti-Qa-5 and  rabbit  complement  (final 
dilution 1:10) for 35 min at 37°C, or in a two-step procedure with anti-Lyt-1.2, anti-Lyt-2.2, or 
anti-Lyt-2.2, or anti-Ly-5.1 (30 min at room temperature) and rabbit complement 1:10 for 35 
rain at 37°C with frequent dispersal. 
Cytotoxicity Assay.  The nonadherent population of the cultured cells was harvested, washed 
once,  and  the cytotoxie activity was  assayed using a  6-8-h  SlCr release assay as described 
previously (13).  Spontaneous 5ZCr release from HeLa-Ms cells was  10-15%, and  10-20% from 
P815 cells. 
Interferon and T Cell Growth Factor Preparations 
IFN.  107 cells/ml of normal CBA/J spleen cells were co-cultured with monolayers of HeLa- 
Ms cells in RPMI  1640-0.5%  FCS medium for 24 h. The culture supernates were centrifuged 
to remove cells, concentrated 50 times by ammonium sulfate precipitation (40-85% saturation), 
and, after dialysis against three 500  vol of 50 mM potassium phosphate buffer, pH 6.0, the 
sample was applied to a Bio-Gel P100 column (200 ml volume). Each fraction was assayed for 
IFN activity, and IFN-positive fractions were pooled and concentrated by ammonium sulfate 
to a  specific activity of ~ 105 U/mg protein. The characteristics of HeLa-Ms-induced mouse 
IFN were  the  following:  (a)  molecular weight  ~40,000,  with  a  minor peak at  20,000;  (b) 
completely resistant to pH 2.0 treatment for 24 h;  (c)  neutralized by anti-mouse IFN serum 
(generously  supplied  by  Dr.  Ion  Gressor,  Centre  National  de  la  Recherches  Scientifique, 
Villejuif, France). 
INTERLEUKIN 2 (IL-2).  101 cells/ml of B/6 and BALB/c +/+  or BALB/c nu/nu spleen cells 
were co-cuhured (mixed lymphocyte culture) (MLC) in RPMI 1640-0.5% normal mouse serum 
(NMS)  medium  for  30-48  h.  The  culture  supernates  were  pooled  and  concentrated  by 
ammonium sulfate precipitation (50-100% saturation). The precipitate was resuspended in 20 
mM Tris, 0.15  M  NaCI, pH  7.2, dialyzed against the same buffer, and applied to a  Bio-Gel 
P 100 column (200 ml volume). Each fraction was assayed for both IFN activity and eytotoxicity- 
enhancing  activity, the latter by culturing normal spleen cells with  5-10%  vol:vol of each 
fraction for 2 d and examining the eytotoxicity of the cells on HeLa-Ms cells. As shown in Fig. 
1, cytotoxicity-enhancing activity was observed in two peaks. The first peak (45,000  tool wt) 
corresponded with the peak of IFN activity, whereas the second peak (35,000 mol wt) was free 
of IFN activity. Preliminary experiments showed that production of both factors was dependent 
on the Thy-1 +, Lyt-1 +, Lyt-2-, Qa-5- cell population, indicating both IFN and the cytotoxicity- 
enhancing activity used in these experiments derived from T  cells. The second peak will be 
referred to as IFN-free IL-2, and was used at a concentration of 5-10% vol:vol. 
Results 
Heterogeneity of the Phenotype of Spontaneous Killer Cells Generated in Cultures of Lymphoid 
Organs  of Normal  Mice.  Cells  from  mouse  spleen,  bone  marrow,  and  thymus  of 
C57BL/6  +/+  (B/6), nu/nu, and be~be mice were cultured in medium for 4-5 d, and 
the cytotoxic activity of the nonadherent populations was assayed against two different 752  ON THE HETEROGENEITY OF  NATURAL KILLER CELLS 
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FiG.  1.  Separation of IL-2 from IFN activity in MLC supernates. MLC supernates (48 h) were 
concentrated 50 times and applied to a Bio-Gel  P 100 column as described in Materials and Methods. 
Each fraction was assayed for IFN (antiviral) activity (shaded area) and NK-enhancing activity 
(O). The latter was expressed as the increase in percent specific SXCr release on HeLa-Ms cells 
(percent specific 51Cr release by the spleen cells cultured 2 d with 10% vol:vol of each column 
fraction/percent specific S~Cr release by the spleen cells cultured 2 d with 10% vol:vol column 
buffer). (----),  A280 of each fraction. 
target ceils, namely HeLa cells persistently infected with measles virus (HeLa-Ms), an 
NK-sensitive target similar to YAC-1, and P815  mastocytoma cells, an NK-resistant 
tumor cell. To clarify the serologic phenotypes of the effector cells on each target, the 
cultured  cells  were  treated  with  various  antisera  in  the  presence  of complement, 
including  anti-Thy-1.2, anti-Qa-5, anti-Ly-2.2, and anti-Ly-5.1 just before the assay 
for cytotoxicity. The results of the selective depletion experiments are summarized in 
Table I. It is clear that at least four serologically distinct cytotoxic populations exist 
or  can  be  generated  in  cultures  of normal  B/6  lymphoid  organs.  They  are  the 
following: (a) Thy-1 +, Q a-5-, Lyt-2  +, Ly-5  + cells generated from spleen, but not from 
bone marrow, which are cytotoxic to allogeneic P815  targets and ineffective against 
HeLa-Ms  cells  (Table  I,  A2,  B1);  (b)  Thy-l-,  Qa-5 +,  Ly-5  +  cells  generated  from 
spleen and cytotoxic only to HeLa-Ms (or YAC cells), but not P815 targets (Table I, 
AI, 2);  (c) Thy-1 +, Qa-5 +, Ly-5  + cells, also cytotoxic for HeLa-Ms or YAC-1 but not 
P815  (Table I, A1, 2); and (d) Thy-, Qa-5-, Lyt-2-, Ly-5  + cells found preferentially 
in cultures of bone marrow and effective only against HeLa-Ms (or YAC) target cells 
(Table I, B 1). No spontaneous killer cells were generated under these culture condi- 
tions  from  thymus  cells.  It  is  noteworthy  that  all  NK subsets  expressed  the  Ly-5 
surface antigen. 
The first type of NK cell (Thy-1  +, Qa-5-, Ly-2  +) could not be generated in cultures 
of B/6 nu/nu cells (Table I, A3). Because the serological phenotype of this population 
corresponds to  that  of conventional  alloreactive T  killer cells,  it will be designated 
here as the T  killer  (TK)  subset. The second type of cytotoxic cell  (Thy-l-, Qa-5 +, 
Lyt-2-) exists in primary spleen cells, but was not found in either primary or cultured 
B/6 be~be spleen cells  (Table I, A4).  These characteristics,  as well as the serological 
phenotype, correspond most closely to those of the NK cell described in most of the 
systems reported, and will be referred to here as the NKI subset, because it is regulated 
by IFN, as will be described later. The third type of cells representing 30-40% of the 
NK activity in spleens of normal or nude  mice was similarly Qa-5 + and Ly-5  +, but NAGAHIRO MINATO, LOLA REID, AND BARRY  R.  BLOOM  753 
TABLE  I 
Heterogeneity of the Serological Phenotypes of Spontaneous Killer Cells Generated in the Cultures of Mouse 
Lymphoid Organs 
Effector source  Target cells  Cytotoxicity 
Percent reduction of cytotoxicity 
Anti-Thy-  Anti-Qa-5  Anti-Lyt-  Anti-Ly-5.1 
1.2  2.2  (plus C) 
A.  Spleen 
I.  B/6 +/+  HeLa-Ms  20  35  100  0  84 
fresh  P815  0  --*  --  --  -- 
2.  B/6 +/+  HeLa-Ms  17  75  75  0  70 
4-d culture  P815  23  100  40  80  94 
3.  B/6 nu/nu  HeLa-Ms  43  80  65  0  70 
4-d culture  P815  0  .... 
4.  B/6 be~be  HeLa-Ms  0  .... 
fresh 
B/6 be/be  HeLa-MS  0  .... 
4-d culture 
B,  Bone marrow 
1.  B/6 +/+  HeLa-Ms  20  0  l0  0  100 
4-d culture  P815  0  .... 
2.  B/6 nu/nu  HeLa-Ms  28  55  55  0  -- 
4-d culture  P815  0  .... 
3.  B/6 be/be  HeLa-Ms  25  0  0  0  100 
4-d culture 
C.  Thymus 
B/6 +/+  HeLa-Ms  0 
4-d culture  P815  0 
q 
4 
Spleen, bone marrow, or thymus cells  from 6-8-wk-old mice were cultured in RPMI  1640-10% FCS 
medium for 4 d.  Fresh or cultured cells were treated with C  alone or various antisera plus C, and the 
cytotoxicity was assayed on HeLa-Ms or P815 cells using the 6-h 5~Cr release assay at a lymphocyte to 
target ratio of 100:1. Assays were performed in triplicate and each value represents  the mean of two to 
three independent experiments. 
* Not applicable. 
also expressed the Thy-1.2 antigen and is designated the NKT subset. The fourth type 
of NK  cell, expressing only the  Ly-5  marker,  was  found  primarily  in  cultured  bone 
marrow  cells.  In  contrast  to  NKt  and  NKT  cells,  these  effector cells were  generated 
equally well  in  cultures  of bone  marrow  ceils  from  B/6  +/+,  nu/nu, or be~be mice. 
Because these cells are clearly distinct  from the other subsets,  they will be designated 
NKM cells, because  their presence was restricted  to bone marrow.  As shown  in Table 
I, B2, cultured nu/nu bone  marrow  cells have both  NKT and  NKM activity, whereas 
in  conventional  and  be~be mice  (Table  I,  B1,  B3),  NKM  cells  appear  to  be entirely 
responsible for the cytotoxicity of bone marrow cultures against HeLa-Ms  target cells. 
Selective Induction of NKz and NKT but not NKM or TK Subsets of Cytotoxic Effector Cells by 
IFN.  We examined the effect of mouse IFN on the generation of three phenotypically 
distinct  subsets  described  above.  Normal  B/6  +/+  spleen,  bone  marrow,  or thymus 
lymphocytes  were  cultured  in  the  presence  or  absence  of  1,000  U/ml  of partially 
purified  IFN.  After  varying  intervals,  the  cells  were  harvested,  and  their  cytotoxic 754  ON  THE  HETEROGENEITY  OF  NATURAL  KILLER  CELLS 
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FxG.  2.  Effect of IFN on the generation of eytotoxic activity in spleen, bone marrow, and thymus 
cell cultures of B6 mice. The cells were cultured with (O) or without (O)  1,000 U/ml of partially 
purified mouse IFN. At various intervals, the cells were harvested, washed, and the cytotoxicity was 
assayed on HeLa-Ms cells (solid lines) or P815 cells (dotted  lines) at a  lymphocyte to target cell 
ratio of 40:1. Each point represents the mean of triplicate cultures. 
activity on HeLa-Ms and  P815 cells was  assayed.  As shown in Fig.  2,  IFN rapidly 
enhanced the cytotoxic activity of spleen and bone marrow cells on HeLa-Ms cells 
within  12 h  after addition, reaching a  peak at  1-2 d  of culture. After this peak, the 
cytotoxic activity of the cultures rapidly declined, generally showing less activity than 
comparable untreated control cultures at  3-5 d. This apparent depressive effect on 
IFN after transient stimulation was more pronounced in bone marrow than in spleen 
cell cultures. The cytotoxic activity on P815 cells was not augmented by IFN and was 
depressed  in  the  later  phases  of culture,  indicating  that  the  TK  cells  were  not 
responsive to IFN. 
To ascertain the cell types on which IFN was active, reexamination of the phenotype 
of effector cells after IFN treatment in cultures was necessary. The results presented 
in Table II, A1  indicate that the cytotoxicity of B/6 +/+  spleen cells was enhanced 
by IFN, and the phenotype of the effeetor cells generated remained that of the NKx 
and NKT cells, the only difference being that there was a significant increase in the 
percentage of these cells that were Thy-1.2  + after IFN treatment. On the other hand, 
although the cytotoxicity of the bone marrow cell cultures was enhanced by IFN, the 
predominant phenotype of the effectors derived from IFN-treated cultures was found 
to be that of NKT and NKI cells (Table II, B1), whereas the phenotype of effectors 
obtained from cultures not treated with IFN was clearly that of NKM cells. This result 
strongly suggests that the increase in cytotoxicity of bone marrow cells provided by 
IFN is actually a  result of the differentiation of NKI precursors into the functional 
effector cells, rather than of stimulation of NKM cells. 
The possibility that IFN acted on NKM cells and converted their phenotype into 
that of NKI cells was excluded by experiments shown in Table II, B3, 4.  B/6 be/be 
mice lack functional effector cells of the NKx phenotype, but have competent effector 
cells  of the  NKM  type.  IFN  treatment  of B/6  be/be mouse  spleens  induced  no 
significant cytotoxic activity on HeLa-Ms cells (Table II, A3), indicating that be~be 
mouse spleens functionally lacked IFN-sensitive precursor cells as well as NKI and 
NKT effector cells.  Bone marrow cells of be/be mice  (Table II, B3) showed normal 
cytotoxic activity on HeLa-Ms cells mediated by the NKM phenotype, and IFN failed 
to  enhance,  and  somewhat  depressed,  this  activity.  Secondly,  the  IFN  failed  to 
augment NK activity on the spleen and bone marrow cells of B/6 mice pretreated NAGAHIRO MINATO, LOLA REID, AND BARRY  R.  BLOOM 
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Effector source  IFN  Cytotoxicity 
Percent reduction of cytotoxicity 
Anti-Thy-  Anti-Qa-5  Anti-Lyt-  Anti-Ly-5.1 
1.2  2.2  (plus C) 
A.  Spleen 
1.  B/6 +/+ 
2.  B/6 nu/nu 
3.  B/6 be~be 
4.  B/6 +/+ 
(aQa-5  plus 
¢), 
B.  Bone marrow 
1.  B/6 +/+ 
2.  B/6 nu/nu 
3.  B/6 be~be 
4.  B/6 +/+ 
(aQa-5 plus 
c), 
% 
-  20.9  25  100  0  85 
+  46.3  55  100  0  100 
-  14.3  30  84  0  --* 
+  60.0  72  95  0  -- 
-  3.5  .... 
+  3.4  .... 
-  3.5  .... 
+  3.5  .... 
-  25.2  0  20  0  100 
+  48.8  65  70  0  100 
-  12.6  19  31  --  -- 
+  27.9  58  72  --  -- 
-  24.8  0  0  --  100 
+  14.9  0  0  --  100 
-  24.8  0  0  --  -- 
+  20.4  0  14  --  -- 
Spleen or bone marrow cells of various mice were cultured in the presence  or absence of 1,000 U/ml of 
IFN for  1 d. The cells were harvested, washed, and treated with C alone or various antisera plus C as 
described in Materials and Methods. They cytotoxicity of these cells on HeLa-Ms was assayed  using a 
6-h 51Cr release assay at a lymphocyte to target ratio of 50:1. Assays were performed in triplicate, and 
each value represents  the mean of two independent experiments. 
* Not tested. 
:~ The cells were pretreated with anti-Qa-5 plus C before the initiation of the culture. 
with  anti-Qa-5  plus complement  ((2),  which  eliminates  both  the NKx precursor  and 
effector cell, although  NKM  activity of comparably  treated  bone  marrow  remained 
unaffected  (Table II, B4). 
We  believe  these  results  indicate  that  NKI  and  NKM  cytotoxic  cells  represent 
distinct and independent  populations  and that  only the former are responsive to IFN. 
T  Cell Growth Factor Preparation  Lacking IFN Activity Can Stimulate NKT as well as  TK 
but not NKt or NKM Cytotoxic  Activity.  It is well established that an antigen-nonspecific 
growth  factor  (IL-2)  is involved in  the generation  of specific alloreactive eytotoxic T 
cells,  and  can  be  used  in  establishing  continuous  T  cell  lines  (14).  To  assess  the 
responsiveness of the various NK cell subsets to IL-2 activity, it was crucial to separate 
chromatographically  the IL-2 activity from IFN activity that could also augment  NK 
activity in the cultures perhaps for different reasons. The addition of partially purified 
IL-2  at  a  final  10%  concentration  facilitated  the  generation  of cytotoxicity  by  B/6 
spleen cell cultures to both HeLa-Ms  and P815 cells, although the kinetics of induction 
was slower than  those of IFN  (Fig. 3). 
The  serological  phenotypes  of the  effector cells generated  by  the  IL-2  were char- 756  ON  THE  HETEROGENEITY OF  NATURAL KILLER CELLS 
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FIB.  3.  Effect  of partially purified IL-2 on the generation of cytotoxic activity in spleen,  bone 
marrow, and thymus cell cultures of B6 mice. The cells were cultured with (0) or without (O)  10% 
vol:vol T  cell  growth  factor.  At  various  intervals,  the  cells  were  harvested,  washed,  and  the 
cytotoxieity was assayed on HeLa-Ms cells (solid lines) or P815 cells (dotted lines) at a lymphocyte 
to target cell ratio of 40:1. Each point represents  the mean of triplicate cultures. 
TASt.E  III 
IFN-free IL-2 Stimulates Both NKT and TK Cells without Affecting NKM Cell Activity 
Effector source  T-F  Target cells  Cytotoxicity 
Percent reduction of 
cytotoxiclty 
Anti-Thy-  Anti-Qa-5 
1.2  plus C 
B/6 +/+ spleen 
% 
-  HeLa-Ms  6.3  --*  -- 
+  HeLa-Ms  42.8  74  53 
-  P815  2.5  --  -- 
+  1)815  35.6  98  0 
B/6 +/+ bone marrow  -  HeLa-Ms  19.0  0  0 
+  HeLa-Ms  38.1  67  60 
B/6 aQa-5 plus C-treated bone  -  HeLa-Ms  29.9  0  0 
marrow  +  HeLa-Ms  25.5  0  0 
Normal B/6 spleen,  bone marrow cells, and bone marrow cells pretreated with anti-Qa-5 plus C were 
euhured for 5 d in the presence or absence of IL-2 (10% vol/vol) in RPMI 1640-I0% FCS medium. The 
cells were harvested, washed,  and treated with C alone,  anti-Thy-l.2 plus C, or anti-Qa-5 plus 12. The  sl,  cytotoxicity was then assayed on HeLa-Ms or P815 cells using a 6-h  Cr release assay at a lymphocyte 
to target ratio of 20:1. Each value represents  the mean of triplicate assays. 
* Not tested. 
acterized,  and  the  results  are  summarized  in  Table  III.  Essentially  all  cytotoxic 
activity of HeLa-Ms  cells and P815 cells generated in spleen cell cultures by IL-2 was 
eliminated by anti-Thy-1.2  plus C.  In addition,  the cytotoxicity on P815  targets was 
totally resistant  to anti-Qa-5  plus C, whereas that on HeLa-Ms  cells was significantly 
reduced by anti-Qa-5  plus C  treatment.  These results indicate that  IL-2 is capable of 
stimulating  two  different  sets  of effector cells,  namely  the  NKT  subset  of cytotoxic 
cells, which  express  Thy-l.2 +  and  Qa-5 +, and  TK  cells, which  are Thy-l.2 +, Qa-5-. 
The  cytotoxic  activity  on  HeLa-Ms  cells  from  bone  marrow  cultures  generated  by 
IL-2 was sensitive to both anti-Thy-1.2  and  anti-Qa-5  plus C  treatments  (NKT cells), 
whereas that in control cultures was resistant to both treatments.  Because the cytotoxic 
activity  in  bone  marrow  pretreated  with  anti-Qa-5  plus  C  could  no  longer  be NAGAHIRO  MINATO,  LOLA  REID,  AND  BARRY  R.  BLOOM  757 
stimulated by the addition of IL-2 to the cultures, we infer that the NKM cell was not 
responsive to IL-2. In summary, these results indicate that IFN-free IL-2 can stimulate 
NKT as well as TK cell activity without affecting NKM cell activity. Because the NK 
effector cells induced by IL-2 were predominantly Thy-1 + NKT cells, and because the 
alloreactive cytotoxic cells cultured from nude mouse spleens in the presence of IL-2 
were totally Thy-1 + (15), it would appear that IL-2 acts primarily, if not exclusively, 
on Thy-1 + cells. 
IFN and IL-2 Act on Phenotypically Different Sets of Cells.  The results described above 
show that both IFN and IFN°free IL-2 can induce phenotypieally indistinguishable 
cytotoxic effector cells expressing the Thy-1 + phenotype capable of killing HeLa-Ms 
cells, yet the time-course of development of these effector cells suggested the mecha- 
nism of action of these two factors may be quite different. The phenotype of the cells 
upon which each of these factors acted remained to be established. 
Normal spleen cells were pretreated with anti-Thy-l.2 plus C, with anti-Qa-5 plus 
C  or with C  alone. The remaining cells were then cultured in the presence of IFN, 
IL-2, or medium alone. As shown in Fig. 4, IFN enhanced the cytotoxic activity of 
Thy-l+-dependent  spleen  cells  as  efficiently as  in  the  untreated  control  cultures, 
whereas Qa-5+°depleted cells failed to show any augmented eytotoxicity induced by 
IFN. Thus the phenotype of the IFN-responsive cell could be defined as the Thy-l-, 
Qa-5 +, NKI precursor cell confirming our previous results (12). In contrast, IL-2 failed 
to  enhance  the  cytotoxic activity of either  Thy-l.2  or  Qa-5-depleted  spleen  cell 
cultures,  indicating  that  the  phenotype of the  target  cells of IL-2  is  the  Thy-1 ÷, 
Qa-5 +, NKT cell. It thus appears that IFN can act on Thy-l.2- population, whereas 
IL-2 can act only on Thy-1 ÷ cells.  This was extended by demonstrating that  IL-2 
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Fro.  4.  Comparison of the effects of IFN and IL-2 on the generation of cytotoxic activity in the 
spleen cells depleted  of Thy-1  + cells or Qa-5  + cells.  Normal B6 +/+  or nu/nu spleen cells were 
treated with C  alone, anti-Thy-l.2 plus C, or anti-Qa-5 plus C, washed, and then cultured in the 
absence (['-l), or presence of 1,000 U/ml IFN (1~) or  10% vol/vol T  cell growth factor  ([]) for  I or 
4 d, respectively. The cells were harvested, washed, and the cytotoxicity was assayed on HeLa-Ms 
cells (a, b, c) or P815 cells (d), using the 61Cr release assay at 6 h. The lymphocyte to target cell ratio 
was 40:1. The means of triplicate euhures of at least three independent experiments are shown. 758  ON  THE  HETEROGENEITY  OF  NATURAL  KILLER  CELLS 
failed  to  induce  TK  cells  from  anti-Thy-l.2  plus  C-pretreated  spleen  cells,  thus 
confirming that IL-2 acts only on Thy-1 + cells. 
Discussion 
Although  it  is generally accepted that  NK cells constitute a  functionally distinct 
cytotoxic defense mechanism, in most discussions of the provenance and characteristics 
of these cells it has been assumed that there is in fact only a single species of NK cell. 
A  wide  variety of experimental  data  increasingly support  the  view  that  there  are 
multiple cell types, perhaps derived from different cell lineages, which can exert NK- 
like spontaneous cytotoxicity in vitro (2,  7-11,  16,  17). The aim of the present work 
was to delineate and characterize the diversity of functional NK cells in the mouse in 
terms of a  number of genetically controlled surface markers.  Our findings indicate 
that  at  least  four phenotypically distinct classes of NK effector cells can be distin- 
guished.  At  the risk of burdening  an already confusing nomenclature, we found it 
convenient  to  refer to  these  subsets  as  NKI,  NKT,  and  NKM,  and  TK cells.  The 
characteristics of these serologically distinguishable  populations are summarized in 
Table IV. To this list one must add the natural cytotoxic (NC)  cell that  lyses solid 
tumor cells but  not lymphomas, and expresses none of the surface markers studied 
here (18), although it is possible that it is related to the NKM subset. 
The existence of distinct NK effector cell types was strengthened by studies on the 
selective regulation of the activity of each subset by two different biological factors. 
In  the  results  described  here,  exogenous  IFN  selectively  induced  NKx  and  NKT 
activity without  augmenting  NKM or TK activity  (Table II).  We have  previously 
found that the anti-Thy- 1 sensitivity of NK activity of  spleens of nude mice preinjected 
with virus persistently infected tumor cells (50-55%) was always greater than that of 
normal  mice  (25-35%).  In  data  not  shown,  we  observed  a  small  but  significant 
increase in anti-Thy-l-sensitive NK activity upon the addition of IFN to spleen cells 
in vitro. Although the results may not be definitive they suggest that IFN may have 
several effects on NK cells: (a) it was indicated that IFN can stimulate noncytotoxic 
Qa-5 + Ly-5- precursor cells to differentiate into Qa-5 + Ly-5  ÷ NKx effector cells (12); 
TABLE  IV 
Characteristics of Four Subsets of Spontaneously Cytotoxic Cells in Mice 
NKr  NKT  TK  NKM 
Serological phenotype  Thy- 1-, Lyt-2  Thy-1 +, Lyt-2-  Thy-1 ÷, Lyt-2 +  Thy- 1-, Lyt-2- 
Qa-5 +, Ly-5 +  Qa-5 +, Ly-5 +  Qa-5-, Lyt-5 +  Qa-5-, Lyt-5 + 
Target cell lysis 
HeLa-Ms (or YAC-1)  +  +  -  + 
P815  -  -  +  - 
Regulated by IFN  +  Not tested  -  - 
Regulated  by IL-2  -  +  +  - 
Organ distribution 
Bone marrow  -- (+)  [-]  -- (+)  [+]  -- (-)  [--]  +  (-)  {-] 
Spleen  +  (+)  [-]  +  (+)  [+]  +  (-)  [+]  -  (-)  [-] 
-(-)  [-I  -(-)  [-]  -(-)  [-]  -(-)  l-] 
Activity in be~be  mice  -  -  +  + 
Activity in nu/nu mice  +  +  -  + 
Parentheses  activity  augmented  after  treatment  with  IFN;  Brackets  indicate  activity  augmented  after 
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(b)  IFN may convert a  portion of NKI to NKT cells;  and  (c)  IFN can increase the 
effectiveness of some NK cells in lysing targets (19). 
Both IFN and a partially purified IL-2 augmented NK activity in these experiments, 
although they clearly acted on  different subsets.  IFN-free IL-2  preparations  aug- 
mented the activities of TK and NKT subsets, but not NKI or NKM cells. Interestingly, 
IL-2 augmented NK activity in spleen cells obtained from both conventional and 
nu/nu mice, but was without effect on spleen cells of nu/nu mice depleted of Thy-1.2  + 
cells  with  monoclonal  anti-Thy-l.2.  The  data  of Hunig  and  Bevan  (15) on  the 
requirement for preexisting Thy-1 ÷ cells in nude mouse spleens for the development 
of H2-specific cytotoxic T  lymphocytes (CTL) and their amplification in vitro, and 
Dennert's (20) development, using IL-2, of Thy-1 ÷ NK lines corresponding with our 
NKT cells,  together with  the data presented  here,  strongly suggest  that  IL-2  acts 
primarily, if not exclusively, on Thy-1 ÷ cells. 
One  hypothesis  consistent  with  these  data  would  hold  that  IFN  induces  the 
differentiation of precursor cells into NKI effector NK cells and subsequently converts 
a  portion of them into NKT effector cells.  These Thy-1 ÷ NKT cells could then be 
regulated and expanded by IL-2. 
Further evidence of the independence of these subclasses derived from studies on 
be~be and nu/nu mice. As has been reported previously (21) be~be  mice lack functional 
NK cells, but clearly possess  target-binding cells, and in the present studies lacked 
Qa-5 ÷ NK cell activity, i.e., functional NKx and NKr ceils. Beige mice possess normal 
TK and NK~ activity. Conventional mice depleted of Qa-5 ÷ cells with anti-Qa-5 
plus C proved to be functionally equivalent to be~be  mice. Conversely, nu/nu mice lack 
TK  ceils,  but  have  normal  NKI  and  NKT,  as  well  as  NKM  activity.  Whereas 
spontaneous cytotoxicity of all three classes of cells was eliminated by treatment with 
anti-Ly-5  plus  C,  in  the  absence  of complement,  anti-Ly-5  selectively blocks  the 
activity of NKI cells, but not of NK~ or TK cells. 
Two important  questions clearly require  further study: the relationship of these 
separate subsets to the conventional lymphoid cell lineages, and the role, if any, of 
these subclasses in immune responses in vivo. Of particular interest is the relationship 
between NKx, NKT, and TK and CTL. It remains to be established whether the NKT 
cells, which can be amplified by IL-2, can differentiate further to become TK cells, 
which would require acquiring the Lyt-2 surface marker and losing the Qa-5 marker. 
The TK cells express the same phenotype as conventional CTL. It is unclear whether 
their  activity represents  polyclonal activation of conventional CTL in  culture, or 
whether they are  a  T  cell  subset  that  functions physiologically as  NK cells.  The 
relationship between NK and T  cells is not a  trivial problem, because at issue are 
questions regarding differentiation of functional cytotoxic T ceils through thymic and 
extrathymic pathways and  possible antigen-specific recognition and repertoire.  Fi- 
nally,  if one  accepts  the  existence  of at  least  four  subclasses  of cells  capable  of 
mediating spontaneous  cytotoxicity in  vitro,  it  will  be  important  to  establish  the 
relative importance, if any, of each in vivo. 
There is strong evidence that cells of the NKI and NKT subclasses do operate in 
vivo because systems have been described in which IFN induces resistance to tumor 
growth  or  virus  infection in  vivo  (22,  23)  under conditions where it  is  ineffective 
directly in vitro, suggesting that resistance in vivo must be mediated via some host 
cell  mechanism.  We  have  recently  reported  that  anti-IFN  serum  suppresses  the 760  ON THE HETEROGENEITY OF NATURAL KILLER CELLS 
resistance  of nu/nu  mice  to  virus  persistently  infected tumor  cells,  and  that  these 
tumors  not  only  grow  invasively in  most  treated  mice,  but  also  metastasize  in  a 
significant  portion  as  well  (24).  Similar  results  using  anti-asialo  GM1  antibodies 
reactive with NK cells have recently been observed by Habu et al. (25). 
Summary 
The heterogeneity of cells capable of exerting spontaneous cytotoxicity in vitro was 
explored using antisera to several genetically determined surface markers on mouse 
lymphocytes. Four phenotypes of cells derived either from fresh or cultured murine 
lymphoid tissue were found to exert natural killer (NK) activity in vitro. One effector 
cell subset, termed NKI cells, had the serological phenotype of Thy-1-, Lyt-2-, Qa-5 ÷, 
and  lysed measles  virus persistently infected target  cells  (HeLa-Ms)  but  not  P815 
mastocytoma cells.  It  corresponds with  the  NK cells described in  most  systems  in 
which lymphoma targets are commonly used. A second subset, with the same target 
cell specificity, termed NKT is a thymus-independent cell with the phenotype Thy-1 +, 
Lyt-2-, Qa-5 +, Ly-5  +. A third subset of NK cells, termed T  killer (TK) cells, deriving 
from cultures of conventional but  not  nude  mouse spleens,  mediated  spontaneous 
cytotoxicity of P815  mastocytoma cells,  but  not  of virus-infected targets.  It  has  a 
phenotype of Thy-1  +, Lyt-2  +, Qa-5-, Ly-5  +, apparently identical with that of conven- 
tional, antigen-specific cytotoxic T  lymphocytes. The fourth phenotype of NK cells, 
termed NKM, derived primarily from cultures of bone marrow, is cytotoxic for HeLa- 
measles but not P815, and expresses only Ly-5  + among the various markers tested. 
Beige mice possess normal TK and NKM activities, but were deficient in NKI and 
NKT activity. Conversely, nude mice lacked TK cells, but had normal NKI, NKT as 
well as NK~ activity. All NK cell subsets express the Ly-5 surface marker. 
The existence of four phenotypically distinct NK effector cells was strengthened by 
studies  on  selective regulation  of their activity by two  different biological  factors. 
Interferon (IFN) augmented NK activity of primarily one of the subsets examined, 
the NKI cell; the activity of IFN on NKT cells could not be directly tested, but IFN 
was without positive effect on TK or NKM cells.  In contrast, partially purified IFN- 
free interleuken 2 (IL-2) augmented the activities of both the TK and NKT subsets, 
but not of NKI or NKta cell.  IL-2 was  active in augmenting NK activity in spleen 
cells obtained  from both conventional and  nu/nu  mice, but  was  without  effect on 
spleens of nu/nu  mice depleted of Thy-1  + cells.  These and  other data suggest  that 
IL-2 acts primarily, if not exclusively, on Thy-1  + cells. 
These results strengthen the view that natural cytotoxicity in vitro can be mediated 
by several distinct cell populations under different genetic and regulatory control and 
indicate the importance of defining and delineating the cell lineages of each and the 
role of the independent subsets in resistance to virus infections and tumors in vivo. 
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